Showing results (1-10 of 178) with videos related to
Sort By:
Pageof 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 2022
[Indications and Practice of a New Radionuclide Therapy, 177Lu-DOTATATE in Japan]Shoko Takano, Noritoshi Kobayashi, Yasushi Ichikawa, et al.Case Reports in Oncology|June 14, 2016
Sorafenib Monotherapy in a Patient with Unresectable Hepatic Epithelioid HemangioendotheliomaNoritoshi Kobayashi, Takeshi Shimamura, Motohiko Tokuhisa, et al.Cancer Science|March 10, 2022
Neuroendocrine tumor theranosticsYasushi Ichikawa, Noritoshi Kobayashi, Shoko Takano, et al.Journal of Biochemistry|January 12, 2024
Comparative Analysis of Site-Specific N-glycosylation of LAMP1 from Breast Cancer TissuesShoko Ohashi, Daisuke Takakura, Noritoshi Kobayashi, et al.Medicine|May 11, 2017
Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failureNoritoshi Kobayashi, Takeshi Shimamura, Motohiko Tokuhisa, et al.Surgery Today|September 25, 2012
The current diagnosis and treatment of benign biliary strictureHiroshi Shimada, Itaru Endo, Kazuhiro Shimada, et al.Frontiers in Oncology|February 27, 2023
Targeted O-glycoproteomics for the development of diagnostic markers for advanced colorectal cancerDaisuke Takakura, Shoko Ohashi, Noritoshi Kobayashi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 13, 2010
Clinical classification of congenital extrahepatic portosystemic shuntsNoritoshi Kobayashi, Tetsu Niwa, Hiroyuki Kirikoshi, et al.Endoscopy|July 31, 2013
Positioning of nasobiliary tube using magnet-loaded cathetersSeitaro Watanabe, Takamitsu Sato, Shingo Kato, et al.Cancer Science|January 16, 2021
Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinomaNoritoshi Kobayashi, Yuma Takeda, Naoki Okubo, et al.Pageof 18